Pure Global
NCT05556135

Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease

Assiut University·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Renal Impairment
Drug/Device/Intervention
level of serun adiponectin
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2022
End date
Oct 01, 2023
Enrollment
90 participants
Primary outcome

Correlate serum Adiponectin level with renal impairment in non-alcoholic fatty liver disease.

Summary

Early detection of renal impairment in patients with Non-alcoholic fatty liver disease and
 its correlation with serum Adiponectin level.

ICD-10 classifications
Renal failureDisorders resulting from impaired renal tubular functionDisorder resulting from impaired renal tubular function, unspecifiedOther disorders resulting from impaired renal tubular functionAcute renal failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05556135
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05556135 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Renal Impairment. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.